Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

(Qidong, China, 1977-2000 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Period approach, calendar period					Cohort approach, calendar period
Site	ICD-10	77-81	82-86	87-91	92-96	97-2000	77-81	82-86	87-91	92-96	97-2000
C11	Nasopharynx	15.9	31.4	27.2	25.1	37.7	28.1	22.7	29.9	28.5	27.6
C15	Oesophagus	2.6	6.2	6.6	4.2	5.6	3.6	4.5	5.4	6.8	4.4
C16	Stomach	11.2	13.3	16.2	14.7	21.3	11.8	12.3	14.5	17.4	16.2
C17	Small intestine	8.0	11.9	23.3	13.2	8.6	12.2	8.9	16.5	20.7	5.9
C18	Colon	29.4	27.4	38.5	30.8	47.8	32.1	28.0	25.6	42.0	30.8
C19-20	Rectum	21.6	18.0	26.7	24.9	36.7	22.3	20.6	23.3	27.7	28.2
C22	Liver	2.3	1.2	3.8	4.8	5.6	2.4	1.8	2.4	4.0	5.0
C25	Pancreas	3.5	4.5	5.1	4.6	8.3	5.6	4.0	5.0	4.9	5.2
C40-41	Bone	14.0	16.1	26.6	15.2	16.0	37.4	13.0	19.1	26.6	12.5
C44	Other skin	30.4	16.4	47.0	36.6	46.4	41.0	24.8	17.6	54.6	37.7
C50	Breast	57.1	58.9	59.7	55.4	64.8	56.2	59.4	57.3	61.4	54.2
C53	Cervix	39.1	32.1	40.8	30.6	41.9	56.7	28.7	39.0	35.1	39.8
C56	Ovary	25.9	48.1	34.8	33.8	36.3	30.3	27.5	48.6	31.0	24.2
C61	Prostate	4.5	28.1	22.4	31.2	29.2	14.3	11.4	19.6	29.7	35.0
C64	Kidney	13.9	40.2	40.6	31.5	27.3	31.4	13.9	45.0	34.6	26.7
C67	Urinary bladder	41.0	36.9	37.3	40.6	47.9	31.1	38.5	36.7	45.4	38.9
C70-72	Brain & nervous system	6.4	7.5	7.7	8.9	11.4	10.2	7.1	7.9	10.0	5.0
C82-85+C96	Non-Hodgkin lymphoma	10.8	13.9	23.1	15.7	14.9	11.8	11.3	19.1	21.7	13.5
C90	Multiple myeloma	1.2	3.0	8.8	4.0	13.6	7.9	0.0	7.3	2.1	11.7
C92-94	Myeloid leukaemia	0.0	17.8	7.3	7.6	8.4	4.4	3.9	12.9	11.2	5.3
C95	Leukaemia unspecified	1.1	2.6	12.0	7.6	2.9	2.6	1.6	3.4	8.5	12.1

Graphs:

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table5:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1982-1991 and 1992-2000 (Qidong, China)
- Table6b:	Number of cases by cancer site and calendar period (Qidong, China, 1977-2000)
- Table7:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Qidong, China, 1977-2000 cases followed-up until 2000)

Registry chapter: